Skip to main navigation Skip to search Skip to main content

Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption (vol 142, pg 252, 2012)

  • SD Allard
  • , B De Keersmaecker
  • , Anna Goede
  • , Esther Verschuren
  • , Jeanette Koetsveld
  • , Marleen Reedijk
  • , C Wylock
  • , AV De Bel
  • , J Vandeloo
  • , FHM (Frank) Pistoor
  • , C Heirman
  • , Walter Beyer
  • , Paul Eilers
  • , J Corthals
  • , I Padmos
  • , K Thielemans
  • , Ab Osterhaus
  • , P Lacor
  • , Marchina Ende
  • , JL Aerts
  • Carel Baalen, Rob Gruters

Research output: Contribution to journal › Article › Academic › peer-review

Original languageUndefined/Unknown
Pages (from-to)88-89
Number of pages2
JournalClinical Immunology
Volume150
Issue number1
DOIs
Publication statusPublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC MM-04-27-01
  • EMC NIHES-01-66-01

Cite this